How to choose between IL-17 inhibitors and IL-23 inhibitors for psoriasis

被引：0
|
作者：
Amin, Mina [1 ]
Lee, Erica B. [2 ]
Wu, Jashin J. [3 ]
机构：
[1] Kaiser Permanente, Med Ctr, Dept Med, Los Angeles, CA USA
[2] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA
[3] Kaiser Permanente, Med Ctr, Dept Dermatol, Los Angeles, CA 90027 USA
来源：
JOURNAL OF DERMATOLOGICAL TREATMENT | 2019年 / 30卷 / 04期
关键词：
PLAQUE PSORIASIS; DOUBLE-BLIND; PHASE-III; PLACEBO; EFFICACY; SECUKINUMAB; GUSELKUMAB; MODERATE; SAFETY;
D O I：
10.1080/09546634.2018.1510174
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：374 / 375
页数：2
相关论文
共 50 条
  • [1] Advancements in Biologic Therapy for Psoriasis: the IL-23 Inhibitors
    Hadeler, Edward
    Mosca, Megan
    Hong, Julie
    Brownstone, Nicholas
    Bhutani, Tina
    Liao, Wilson
    CURRENT DERMATOLOGY REPORTS, 2021, 10 (01) : 6 - 15
  • [2] IL-17 and IL-23 Inhibitors Have the Fastest Time to Meaningful Clinical Response for Plaque Psoriasis: A Network Meta-Analysis
    Aggarwal, Pushkar
    Fleischer Jr, Alan B.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [3] Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors
    Huang, Yu-Huei
    Chang, Lun-Ching
    Chang, Ya-Ching
    Chung, Wen-Hung
    Yang, Shun-Fa
    Su, Shih-Chi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [4] Review of IL-17 inhibitors for psoriasis
    Amin, Mina
    Darji, Kavita
    No, Daniel J.
    Bhutani, Tina
    Wu, Jashin J.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (04) : 347 - 352
  • [5] Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis
    Thomas, Sarah E.
    Barenbrug, Liana
    Hannink, Gerjon
    Seyger, Marieke M. B.
    de Jong, Elke M. G. J.
    van den Reek, Juul M. P. A.
    DRUGS, 2024, 84 (05) : 565 - 578
  • [6] IL-23 inhibitors for moderate-to-severe psoriasis
    Ibler, Erin
    Gordon, Kenneth B.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2018, 37 (03) : 158 - 162
  • [7] Newer treatments of psoriasis regarding IL-23 inhibitors, phosphodiesterase 4 inhibitors, and Janus kinase inhibitors
    Wcislo-Dziadecka, Dominika
    Zbiciak-Nylec, Martyna
    Brzezinska-Wcislo, Ligia
    Bebenek, Katarzyna
    Kazmierczak, Agata
    DERMATOLOGIC THERAPY, 2017, 30 (06)
  • [8] The role of IL-23 and the use IL-23 inhibitors in psoriatic arthritis
    Fragoulis, George E.
    Siebert, Stefan
    MUSCULOSKELETAL CARE, 2022, 20 : S12 - S21
  • [9] IL-23 Inhibitors for Psoriasis
    Beck K.M.
    Yang E.J.
    Sekhon S.
    Bhutani T.
    Current Dermatology Reports, 2018, 7 (2) : 119 - 124
  • [10] The Use of IL-17 and IL-23 Inhibitors in Swedish Clinical Practice: A Register-Based Analysis
    Norlin, Jenny M.
    Lofvendahl, Sofia
    Schmitt-Egenolf, Marcus
    DERMATOLOGY, 2023, 239 (02) : 262 - 266
12345